National leaders meet on Holden’s behalf.

The External Advisory Committee of the Holden Comprehensive Cancer Center is composed of experienced leaders from other NCI Designated Cancer Centers.

The committee meets in Iowa City once each year with the leadership, members and staff of the Holden Comprehensive Cancer Center. Committee members provide guidance and consultation to the leadership team of the Holden Comprehensive Cancer Center regarding various aspects of the Cancer Center's activities including:

  • Organizational structure
  • Scientific program development
  • Shared research resources
  • New approaches to strengthening the research, clinical and educational activities of the Cancer Center

Committee Composition

David M. Gosky, MBA, MA

Executive Director-Administration
The Ohio State University Comprehensive Cancer Center
Arthur G. James Cancer Hospital and Richard J. Solove Research Institute
Columbus, Ohio

Maha Hussain, MD, FACP, FASCO

Genevieve Teuton Professor of Medicine
Division of Hematology/Oncology
Deputy Director 
Robert H. Lurie Comprehensive Cancer Center
Northwestern University Feinberg School of Medicine
Chicago

Anita Kinney, PhD, RN, FAAN, FABMR

Professor, Department of Biostatistics and Epidemiology 
School of Public Health
Director, Cancer Health Equity Center of Excellence
Associate Director for Population Science and Community Outreach
Rutgers Cancer Institute of New Jersey
Director, ScreenNJ
Rutgers University
New Brunswick, N.J.

Reuben J. Shaw, PhD

William R. Brody Chair
Professor, Molecular and Cell Biology Laboratory
Director, Salk NCI-Designated Cancer Center
The Salk Institute for Biological Studies
La Jolla, California

Danny R. Welch, PhD

Professor | Department of Cancer Biology
The Kansas University Medical Center
Kansas City, Kansas